A Retrospective Claims Analysis on Rates of Compliance and Discontinuation Among Canadian Multiple Sclerosis Patients Treated with Disease-Modifying Therapies at 6, 12 and 24-Month Periods

OBJECTIVES: To assess compliance and discontinuation rates with DMTs in Canadian patients with RRMS. METHODS: In this Canadian retrospective claims analysis based on Rx Dynamics® data from IMS Health Canada Inc., compliance and discontinuation rates were collected at 6,12 and 24-month (cohorts from...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Value in health 2017-10, Vol.20 (9), p.A719
Hauptverfasser:	Haddad, P, Jobin Gervais, K, Schecter, R, Yeung, M, Duquette, P
Format:	Artikel
Sprache:	eng
Schlagworte:	Autoimmune diseases Compliance Copolymer 1 Discontinued Drugs Interferon Interferon beta Medical treatment Monoclonal antibodies Multiple sclerosis Patients
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!